ETHACRYNIC ACID Drug Patent Profile
✉ Email this page to a colleague
When do Ethacrynic Acid patents expire, and what generic alternatives are available?
Ethacrynic Acid is a drug marketed by Agnitio, Alvogen, Amneal Pharms Co, Chartwell Rx, Edenbridge Pharms, Hikma, Lupin Ltd, Par Pharm Inc, Sciegen Pharms Inc, and Upsher Smith Labs. and is included in ten NDAs.
The generic ingredient in ETHACRYNIC ACID is ethacrynic acid. There are thirteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ethacrynic Acid
A generic version of ETHACRYNIC ACID was approved as ethacrynic acid by EDENBRIDGE PHARMS on June 30th, 2016.
Summary for ETHACRYNIC ACID
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,807 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ETHACRYNIC ACID |
| DailyMed Link: | ETHACRYNIC ACID at DailyMed |
Recent Clinical Trials for ETHACRYNIC ACID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Aptuit Srl | Phase 1 |
| Pari Pharma GmbH | Phase 1 |
| Neupharma Srl | Phase 1 |
Pharmacology for ETHACRYNIC ACID
| Drug Class | Loop Diuretic |
| Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for ETHACRYNIC ACID
US Patents and Regulatory Information for ETHACRYNIC ACID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agnitio | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211809-001 | Jul 12, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Lupin Ltd | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 211719-001 | Sep 6, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Chartwell Rx | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 213240-001 | Oct 19, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Par Pharm Inc | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 208501-001 | Jul 21, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Alvogen | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 205709-001 | Jul 24, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Amneal Pharms Co | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 208805-001 | May 8, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hikma | ETHACRYNIC ACID | ethacrynic acid | TABLET;ORAL | 207262-001 | Feb 23, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
